Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Merck Increases Its Commitment to MS Ventures to 100 millionDarmstadt, Germany, May 16, 2013 - Merck announc…
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Merck KGaA (MRK) hasnt ruled out pursuing its therapeutic cancer vaccine L-BLP25 after a trial showed the tre…
Merck KGaA signaled Thursday that it will make a bigger commitment to investing in emerging biotech companies.
Merck Serono a division of Germany's Merck KGaA MRK DE announced detailed results from the randomized Phase III START trial of its investigational MUC1 antigenspecific cancer immunotherapy LBLP25 form…
